Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Jan. 31, 2025	Jan. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ 18,906,468	$ (1,012,938)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on related party investment – TNF	(21,395,734)	0
Non-cash interest income	(300,000)	0
Stock-based compensation	414,693	674,693
Unrealized gain on marketable equity securities	(72,632)	0
Change in fair value of warrant liability	(8,400,000)	(2,633,000)
Change in fair value of derivative liability	(2,184,000)	663,000
Change in fair value of convertible note receivable	(601,000)	(138,000)
Change in fair value of warrant asset – Femasys	1,830,000	416,000
Change in fair value of investment – TNF	9,765,734	0
Change in assets and liabilities:
(Increase) decrease in prepaid expenses and other current assets	52,438	(190,081)
Increase in accounts payable	95,578	355,918
Increase (decrease) in accrued expenses	(49,470)	45,909
Net cash used in operating activities	(1,937,925)	(1,818,499)
Cash flows from investing activities:
Investment in preferred stock and warrants	(7,000,000)	0
Investment in note receivable and warrants	0	(5,000,000)
Net cash used in investing activities	(7,000,000)	(5,000,000)
Cash flows from financing activities:
Repurchase of common stock, net	(2,370,733)	(27,022,987)
Proceeds from issuance of preferred stock	0	33,650,075
Redemption of preferred stock	(22,486,875)	(6,638,197)
Proceeds from warrant exercise	0	70
Net cash used in financing activities	(24,857,608)	(11,039)
Effect of currency rate exchange on cash and cash equivalents	(975)	(70)
Net decrease in cash and cash equivalents	(33,796,508)	(6,829,608)
Cash and cash equivalents at beginning of the period	50,179,968	68,039,936
Cash and cash equivalents at end of the period	16,383,460	61,210,328
Supplemental disclosure of cash flows information:
Cash paid during the periods for income taxes	0	1,600
Supplemental disclosure of non-cash investing and financing activities:
Non-cash derivative liability at initial fair value	0	2,770,000
Non-cash warrant liability at initial fair value	0	14,127,000
Reclassification of Series B Convertible Preferred Stock and dividends to current liability	16,190,179	4,095,271
Accretion of discounts to redemption value of Series B Preferred Stock	3,193,404	7,733,130
Excise tax accrued on repurchase of common stock	$ 23,707	$ 266,223